Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1986 2
1988 1
1989 1
1990 2
1991 2
1992 2
1995 1
1996 2
1997 1
1999 1
2000 3
2001 2
2003 2
2004 2
2005 2
2006 2
2007 4
2008 2
2009 6
2010 6
2011 5
2012 2
2013 4
2014 3
2015 7
2016 5
2017 4
2018 4
2019 3
2020 4
2021 4
2022 4
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Neuroprotective agents: cannabinoids.
Sánchez AJ, García-Merino A. Sánchez AJ, et al. Among authors: garcia merino a. Clin Immunol. 2012 Jan;142(1):57-67. doi: 10.1016/j.clim.2011.02.010. Epub 2011 Mar 21. Clin Immunol. 2012. PMID: 21420365 Review.
Monoclonal antibodies. Basic features.
García Merino A. García Merino A. Neurologia. 2011 Jun;26(5):301-6. doi: 10.1016/j.nrl.2010.10.005. Epub 2010 Dec 28. Neurologia. 2011. PMID: 21193249 Free article. Review. English, Spanish.
Anti-CD20 monoclonal antibodies in multiple sclerosis.
Moreno Torres I, García-Merino A. Moreno Torres I, et al. Among authors: garcia merino a. Expert Rev Neurother. 2017 Apr;17(4):359-371. doi: 10.1080/14737175.2017.1245616. Epub 2016 Oct 21. Expert Rev Neurother. 2017. PMID: 27718747 Review.
Multidisciplinary Management of the Adverse Effects of Apremilast.
Daudén Tello E, Alonso Suárez J, Beltrán Catalán E, Blasco Maldonado C, Herrero Manso MC, Jiménez Morales A, Marín-Jiménez I, Martín-Arranz MD, García-Merino A, Porta Etessam J, Rodríguez-Sagrado MA, Rosas Gómez de Salazar J, Trujillo Martín E, Salgado-Boquete L. Daudén Tello E, et al. Among authors: garcia merino a. Actas Dermosifiliogr (Engl Ed). 2021 Feb;112(2):134-141. doi: 10.1016/j.ad.2020.08.007. Epub 2020 Sep 7. Actas Dermosifiliogr (Engl Ed). 2021. PMID: 32910923 Free article. English, Spanish.
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.
Meca-Lallana JE, Fernández-Prada M, García Vázquez E, Moreno Guillén S, Otero Romero S, Rus Hidalgo M, Villar Guimerans LM, Eichau Madueño S, Fernández Fernández Ó, Izquierdo Ayuso G, Álvarez Cermeño JC, Arnal García C, Arroyo González R, Brieva Ruiz L, Calles Hernández C, García Merino A, González Plata M, Hernández Pérez MÁ, Moral Torres E, Olascoaga Urtaza J, Oliva-Nacarino P, Oreja-Guevara C, Ortiz Castillo R, Oterino A, Prieto González JM, Ramió-Torrentá L, Rodríguez-Antigüedad A, Saiz A, Tintoré M, Montalbán Gairin X. Meca-Lallana JE, et al. Among authors: garcia merino a. Neurologia (Engl Ed). 2022 Oct;37(8):615-630. doi: 10.1016/j.nrleng.2019.11.001. Epub 2020 Mar 12. Neurologia (Engl Ed). 2022. PMID: 36195374 Free article.
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring.
Kappos L, Bates D, Edan G, Eraksoy M, Garcia-Merino A, Grigoriadis N, Hartung HP, Havrdová E, Hillert J, Hohlfeld R, Kremenchutzky M, Lyon-Caen O, Miller A, Pozzilli C, Ravnborg M, Saida T, Sindic C, Vass K, Clifford DB, Hauser S, Major EO, O'Connor PW, Weiner HL, Clanet M, Gold R, Hirsch HH, Radü EW, Sørensen PS, King J. Kappos L, et al. Among authors: garcia merino a. Lancet Neurol. 2011 Aug;10(8):745-58. doi: 10.1016/S1474-4422(11)70149-1. Lancet Neurol. 2011. PMID: 21777829 Free article. Review.
80 results